Item 2. Properties
Item 2. Properties
Properties for our core operations include our corporate office and headquarters located in Stamford, Connecticut, our primary operating laboratory located in Gaithersburg, Maryland, corporate office space in Oakland, California, and a satellite meeting space located in New York City; each are leased spaces with an aggregate of approximately 120,000 square feet. The lease agreements for these properties expire in 2034, 2031, 2029, and 2026, respectively.
As previously disclosed, we exited our reproductive health and somatic tumor testing business in 2022. We are actively marketing for sublet our two laboratories in Connecticut as well as a portion of our headquarters in Stamford, Connecticut. The lease agreements for these properties expire in 2030, 2034, and 2036, respectively. During the third quarter of 2025, we entered into an agreement to sublet a portion of our headquarters in Stamford, Connecticut.
We believe that our current facilities are suitable and adequate to meet our current needs. See Note 10, “ Leases ” to our consolidated financial statements for more information on our future lease obligations.
Item 3. Legal Proceedings
Information regarding legal proceedings can be found in Note 11, “ Purchase Commitments and Contingencies ” to our consolidated financial statements.
Item 4. Mine Safety Disclosures
None.
54
Table of Contents
Part II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.